HerAnova Presents Validation Data for Endometriosis Blood Test
HerAnova Lifesciences presented validation data for HerResolve, a blood-based endometriosis test, showing 94.4% accuracy and detection of cases missed by imaging.
Tag: biomarkers
All
Latest
All
Latest
Saliva Test May Identify Acute Sleep Deprivation
Researchers identify molecular markers in saliva that could lead to new clinical tests for sleep loss.
All
Latest
Diabetes Testing Expands Beyond Diagnosis Alone
As diabetes testing evolves, labs are seeing growing interest in earlier screening, additional biomarkers, and tools that can support more preventive care.
Creatv Bio’s Liquid Biopsy Test Supports CytoDyn Phase 2 Colorectal Cancer Study
LifeTracDx blood test will evaluate PD-L1 expression changes as exploratory biomarker in trial combining leronlimab with standard therapies.
Read More
New Clinical Data Supports Blood-Based Monitoring for Cancer Treatment Response
Personalis presented data at AACR showing its NeXT Personal assay enabled ultrasensitive ctDNA monitoring for colorectal and lung cancer patients, demonstrating 100% sensitivity at baseline and 100% specificity for relapse post-surgery.
Read More
Routine Lab Tests May Help Identify Physical Effects of PTSD
Researchers at Mass General Brigham identified 16 routine lab markers, including cholesterol and glucose, linked to PTSD’s physical effects, suggesting standard tests could aid in assessing the disorder’s multi-organ impact.
Read More
Boston Cell Standards Moves to Final Phase of FDA Program for Cancer Diagnostic Standards
Boston Cell Standards’ immunohistochemistry reference materials have entered the FDA’s Medical Device Development Tools qualification phase, advancing efforts to standardize IHC assay performance in cancer diagnostics.
Read More
Blood Test Predicts Metastatic Risk in Bladder Cancer Patients Who Keep Their Bladders
Circulating tumor DNA testing may help predict metastatic risk in muscle-invasive bladder cancer patients opting for bladder-sparing treatment, according to Fox Chase Cancer Center researchers, though additional biomarkers are needed for local recurrence.
Read More
Labcorp Launches Companion Diagnostic for Ovarian Cancer Treatment
Labcorp has launched nationwide testing with Agilent’s FDA-approved PD-L1 IHC 22C3 pharmDx, enabling identification of patients with platinum-resistant ovarian cancer eligible for pembrolizumab immunotherapy.
Read More
Blood Test Shows Promise for Detecting Glioblastoma Using microRNA Signatures
A study identified microRNA patterns in blood plasma that could support noninvasive diagnosis and monitoring of the most aggressive form of brain cancer.
Read More
ViewsML Raises $4.9 Million for AI-Based Virtual Tissue Staining
The seed funding will support the commercialization of a platform designed to generate biomarker insights from pathology images without laboratory staining.
Read More
Biognosys and Michael J. Fox Foundation Partner to Develop Parkinson’s Disease Biomarkers
The collaboration focuses on creating sensitive assays for a common genetic risk factor to guide drug development and clinical trials.
Read More
Maternal Blood Test Identifies Autoantibodies Linked to Autism Subtype
The diagnostic tool identifies a specific biological cause of autism with more than 97% predictive accuracy.
Read More
Roche Receives CE Mark for Multiple Sclerosis Blood Test
The Elecsys NfL test measures a protein associated with nerve cell injury to monitor disease activity in patients with relapsing remitting multiple sclerosis.
Read More
Blood-Based Biomarker Identifies Cancer Risk in Lynch Syndrome Patients
Researchers at MD Anderson have identified a blood-based biomarker using T cell receptor sequencing that may help assess cancer risk in asymptomatic Lynch syndrome carriers, according to a study in Nature Communications.
Read More
Trinity Biotech and University at Buffalo Partner to Commercialize Sjögren’s Syndrome Biomarkers
The collaboration focuses on advancing proprietary biomarkers for the earlier and more accurate detection of the autoimmune disease.
Read More
AI-Enhanced Blood Test Improves Early Detection of Leprosy
The diagnostic method combines a multi-antibody blood test with an artificial intelligence-supported questionnaire to identify cases before severe symptoms appear.
Read More
Multi-Cancer Early Detection Test Added to Evexia Diagnostics Platform
20/20 BioLabs’ AI-powered multi-cancer early detection test, OneTest for Cancer, is now available to approximately 40,000 clinicians via the Evexia Diagnostics platform.
Read More